Oligonucleotides are short strands of DNA or RNA that play a major role in drug discovery and molecular diagnostic chip technology. They are used from initial research and screening through to target ...

During an oral Spotlight Presentation, Codexis unveiled the successful end-to-end enzymatic synthesis of an entire approved siRNA therapeutic asset, inclisiran. Codexis enzymatically synthesized the ...

While the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne Muscular Dystrophy and ...

Modern medicine depends on large, information-rich molecules such as peptides and oligonucleotides. These molecules carry biological instructions that can be directed toward specific disease pathways.

TOKYO & NEW YORK & DÜSSELDORF, Germany--(BUSINESS WIRE)--Generating cutting-edge therapeutics requires precision, safety, and efficiency from manufacturing equipment. The next generation of oligo ...

Oligos are playing a crucial role in driving the progress of modern drug development. Listen to nucleic acid synthesis expert Lina Borozdina deliver a complete class on oligo synthesis starting from ...

The oligonucleotide synthesis process can introduce small impurities at various stages. Additionally, different synthesis methods and purification efficiencies can impact sample quality. As such, it ...

Depurination of DNA and RNA sequences is an alteration of the sugar-phosphate backbone in which hydrolysis of a purine base (adenine or guanine) occurs. Synthetic oligonucleotides suffer from such ...

—Management to host conference call on Thursday, November 14 to discuss data— REDWOOD CITY, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading provider of enzymatic solutions for ...

Leverage 40 years of industry expertise at LGC Biosearch Technologies to produce high-quality research grade oligos tailored to your specific needs. Enjoy a wide range of probe chemistries, ...

REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced data from ...